Endoscopic Injection of Mitomycin C for the Treatment of Pharyngoesophageal Stenosis Refractory to Endoscopic Treatment with Dilatation in Patients Treated for Head and Neck Cancer

Table 2

Baseline characteristics of patients with benign and refractory pharyngoesophageal strictures who underwent MMC injection.

	Age		Tumor	Cancer treatment	Time since treatment	Sessions of MMC	Grade of dysphagia before × after	Weight
Patient 1 V. F.	62	F	SCC larynx T4N2M0	Total laryngectomy + CRDT	8 years	3	2 × 1	The same
Patient 2 A. F.	68	M	SCC larynx T4N1M0	Total laryngectomy + CRDT	2 years	2	3 × 3	The same
Patient 3 I. G.	61	M	SCC hypopharynx and cervical esophagus T4bNxMx	CRDT	2, 5 years	2	3 × 4 GTT	The same (gastrostomy)